Mycoplasma pneumoniae attachment to glutaraldehyde-treated human WiDr cell cultures.
Attachment of Mycoplasma pneumoniae to host cells initiates disease, and the attachment components may represent important protective immunogens for preventing disease. We have studied the mechanisms of attachment using in vitro cell culture systems and selected pathogenic and nonpathogenic strains of M. pneumoniae. Attachment of the pathogenic strains M129 and PI-1428 was several fold greater than attachment of the nonpathogenic strain, and attachment of strains M129 and PI-1428 was reduced by 21 to 63% when human WiDr cell monolayers were exposed to neuraminidase, supporting the concept that M. pneumoniae attaches to mammalian cells by a neuraminidase-sensitive glycoconjugate. While attachment of the two pathogenic strains was markedly reduced by treating the WiDr cells with glutaraldehyde, glutaraldehyde treatment produced minimal effects on the attachment of the nonpathogenic strain B176. Glutaraldehyde treatment also altered the temperature dependence of attachment by the pathogenic strains. Because glutaraldehyde-treated WiDr cell monolayers showed little difference in attachment between pathogenic and nonpathogenic strains, glutaraldehyde-treated cells are not appropriate cell substrates for studying M. pneumoniae attachment mechanisms or identifying immunogens for vaccine development.
Izumikawa
K
K
Chandler
D K
DK
Barile
M F
MF
D000447:Aldehydes / Q000494:pharmacology*; D001665:Binding Sites / Q000187:drug effects; D002460:Cell Line; D004847:Epithelial Cells; D004912:Erythrocytes / Q000166:cytology; D005976:Glutaral / Q000494:pharmacology*; D006801:Humans; D009177:Mycoplasma pneumoniae / Q000472:pathogenicity*; D009439:Neuraminidase / Q000378:metabolism; D013696:Temperature
D000447:Aldehydes; D009439:Neuraminidase; D005976:Glutaral